In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
386 News Items found
Pictured: Scott Lowe
In the Lab
Researchers Uncover Potential Target for “Undruggable” Form of Liver Cancer

In taking a new approach to finding treatments for hepatocellular carcinoma, MSK scientists have uncovered a potential drug target for this highly aggressive cancer.
3-D illustration (in pink) of female reproductive system anatomy
Feature
Gynecologic Cancers: The Next Immunotherapy Frontier?

Learn how immunotherapy holds promise for transforming the treatment of gynecologic cancers.
physiatrist Jesuel Padro-Guzman
Q&A
Answers to 8 FAQ About Chemotherapy-Induced Peripheral Neuropathy (CIPN)

Peripheral neuropathy is a common side effect of many types of chemotherapy. Learn about what it is, why it happens, and how to treat CIPN.
Jianjiong Gao, Hongxin Zhang, Nikolaus Schultz, Debyani Chakravarty, and Sarah Suehnholz stand together on a terrace
Feature
A Milestone for Precision Oncology: FDA Gives Green Light to MSK’s Genetic Database

OncoKB, a database developed and maintained by investigators at MSK, helps match patients with targeted therapies based on the mutations found in their tumors.
AACR 2019 Annual Meeting
In the News
AACR 2019 Research Roundup: Pancreatic Cancer Immunotherapy, Prostate Cancer Drug Resistance, Insight into Inherited Cancer Mutations

Read up on the latest developments in several important areas of cancer research emerging from the 2019 American Association for Cancer Research annual meeting.
Two nurses talking at a desk
Feature
On the Front Lines: Meet the Specialized Nurses Helping Move Cancer Research Forward

Deep bonds are forged between MSK’s specialized nurses and their patients during first-in-human trials.
Viviane Tabar in a white coat at a desk with a computer screen in the background
In the Clinic
The Last Frontier in Cancer Care: Treating Disease When It Spreads to the Brain

MSK doctors and scientists are leading the charge to find new and innovative ways to treat metastatic brain cancer.
Ingo Mellinghoff
Researchers Uncover Molecular Interactions in Common Form of Brain Cancer

A multicenter team led by Memorial Sloan Kettering neurologist and researcher Ingo K. Mellinghoff has uncovered the relationship between two proteins that play a critical role in glioblastoma, the most common form of brain cancer.
MSK scientists Margaret Callahan, Ronglai Shen, and Katherine Panageas
MSK Study Identifies Biomarker That May Help Predict Benefits of Immunotherapy

A blood-based test identifies patients in whom immunotherapy may ‘LAG.’
Sign for AACR scientific meeting featuring collage of images
Roundup
Highlights from MSK at the 2018 American Association for Cancer Research Meeting

Read up on the latest developments in several key areas of cancer research, including genomic mapping, disease modeling through CRISPR, CAR T therapy, and cancer stem cells.